Fig. 1
From: Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas
PTPN2 transcript levels increase with tumor grades and in IDH-WT gliomas. a In the CGGA dataset, mRNA levels of PTPN2 were compared between grade II (n = 109) and grade III (n = 72) gliomas, grade IV glioblastoma (GBM; n = 144), and b in IDH-mutant (Mut; n = 158) and IDH wild-type (WT; n = 142) gliomas. c In the TCGA dataset, PTPN2 transcript levels were compared between grade II (n = 216) and grade III (n = 241) gliomas, grade IV glioblastoma (GBM; n = 155), and d IDH-Mut (n = 429) and IDH-WT (n = 234) gliomas